UBS AM’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Buy |
104,705
+48,729
| +87% | +$1.35M | ﹤0.01% | 1973 |
|
|
2025
Q1 | $1.24M | Sell |
55,976
-715
| -1% | -$15.9K | ﹤0.01% | 2216 |
|
|
2024
Q4 | $1.12M | Buy |
56,691
+12,462
| +28% | +$246K | ﹤0.01% | 2314 |
|
|
2024
Q3 | $1.11M | Buy |
+44,229
| New | +$1.11M | ﹤0.01% | 2350 |
|
|
2024
Q2 | – | Sell |
-10,608
| Closed | -$209K | – | 2854 |
|
|
2024
Q1 | $209K | Hold |
10,608
| – | – | ﹤0.01% | 2457 |
|
|
2023
Q4 | $186K | Hold |
10,608
| – | – | ﹤0.01% | 2499 |
|
|
2023
Q3 | $184K | Hold |
10,608
| – | – | ﹤0.01% | 2524 |
|
|
2023
Q2 | $114K | Hold |
10,608
| – | – | ﹤0.01% | 2634 |
|
|
2023
Q1 | $114K | Sell |
10,608
-19,400
| -65% | -$209K | ﹤0.01% | 2634 |
|
|
2022
Q4 | $450K | Hold |
30,008
| – | – | ﹤0.01% | 2212 |
|
|
2022
Q3 | $385K | Sell |
30,008
-5,482
| -15% | -$70.4K | ﹤0.01% | 2436 |
|
|
2022
Q2 | $344K | Hold |
35,490
| – | – | ﹤0.01% | 2431 |
|
|
2022
Q1 | $353K | Hold |
35,490
| – | – | ﹤0.01% | 2552 |
|
|
2021
Q4 | $418K | Hold |
35,490
| – | – | ﹤0.01% | 2615 |
|
|
2021
Q3 | $404K | Buy |
+35,490
| New | +$404K | ﹤0.01% | 2559 |
|